Top of this page
Skip navigation, go straight to the content
Posted by
10-Jul-2014
Posted by HM, 01 October 2014 Excellent, but what new medicines are we talking of? What therapeutic areas are included in Innovative Medicines Initiative (IMI) and what clinical interests are a priority?
Posted by UCB
The goal of the IMI 2 program is to develop next generation vaccines, medicines and treatments, and aims to deliver clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases in just five years. (i.e. Alzheimer’s disease)
The 1st Call for proposals under IMI 2 was launched on 9 July 2014, and the deadline for entry is November 12 of this year. Once the selection is made, we’ll know more about specific targeted treatments.
What is clear is that IMI will focus on addressing scientific challenges where multi-stakeholder input is essential for success, and based on 4 major axes of research:
• Target validation and biomarker research (efficacy and safety)
• Adoption of innovative clinical trial paradigms
• Innovative Medicines
• Patient tailored adherence programmes
Kind regards
Laurent
Leave a Comment